Latest filing published 26 Oct 2021 for SAB Biotherapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Edward D. Hamilton: trading record in brief
Edward D. Hamilton is a declared insider of SAB Biotherapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 1 October 2021 to 22 October 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 26 October 2021, the filings show a share grant worth €24k in SAB Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 13 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward D. Hamilton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,974,497 sharesCommon StockSEC:0001493152-21-026389:0
1 of 1 declaration